No Picture
Aurora Cannabis Inc.

Andrċ Jérôme Appointed Interim CEO of CanniMed

Resigning CEO Brent Zettl to Provide Advisory Services TSX: ACB  TSX: CMED EDMONTON and SASKATOON, April 2, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora“) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (“CanniMed“) (TSX: CMED) announced today […]

No Picture
CanniMed Therapeutics Inc.

CanniMed Therapeutics Inc. Announces Quarterly Results Release Date

CanniMed Therapeutics Inc. Announces Quarterly Results Release Date SASKATOON, Saskatchewan CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) announces that it plans to release its financial results for the three months ended January 31, 2018 before […]

No Picture
CanniMed Therapeutics Inc.

Aurora Cannabis Announces Receipt of Final Regulatory Approval for CanniMed Therapeutics Acquisition and its Intention to Take-Up as soon as Minimum Tender Condition is Met

SASKATOON, Saskatchewan CanniMed Therapeutics Inc. (“CanniMed”) (TSX: CMED) today announced that Aurora Cannabis Inc. (“Aurora”) announced that it has received a No Action Letter from the Competition Bureau (Canada) regarding Aurora’s offer (the “Offer“) to […]

No Picture
CanniMed Therapeutics Inc.

CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need

SASKATOON, Saskatchewan & WATERLOO, Ontario – CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed” or the “Company”) is pleased to announce that today the Company has started fulfilling orders and shipping CanniMed® Topical Cream Kits to registered patients. […]

No Picture
CanniMed Therapeutics Inc.

CanniMed Therapeutics Inc. Announces 2017 Year End Financials Release Date

SASKATOON, Saskatchewan CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) announces that it plans to release its financial results for the year ended October 31, 2017 after close of markets on Monday, January 29, 2018. About CanniMed Therapeutics […]

No Picture
CanniMed Therapeutics Inc.

CanniMed Therapeutics Announces Continued Discussions with Aurora

SASKATOON, Saskatchewan CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc. (“Aurora”). Therefore, CanniMed and Aurora have each agreed to extend their […]

No Picture
CanniMed Therapeutics Inc.

CanniMed Therapeutics Announces Continuation of Discussions with Aurora

SASKATOON, Saskatchewan CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc. (“Aurora”). Therefore, CanniMed and Aurora have each agreed to extend their […]

No Picture
CanniMed Therapeutics Inc.

CanniMed Therapeutics Postpones Special Shareholders’ Meeting

SASKATOON, Saskatchewan CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX:CMED) announces it has determined to postpone the Special Shareholders’ Meeting (the “Meeting”) originally scheduled for January 23, 2018 to Thursday, January 25 at 10:00 am (EST). The cut […]